Demonstration of a new 48-well HPV DNA batch test showing analytical sensitivity to 5000 copies of HPV DNA and other test characteristics that may be suitable for use in low-resource settings. Presented at: 22nd International Papillomavirus Conference, April 30, 2005; Vancouver, BC.

Author: Eder P, Nazarenko I, Peck R, Weigl B, Sellors J, Lorincz A

Publication date: May 2005

Region: Global

The development of a rapid and simple immunochromatographic strip test using the L7/L12 Neisseria gonorrhoeae, testing using clinical samples. Presented at: 15th Biennial Congress, International Society of Sexually Transmitted Diseases Research, July 27, 2003; Ottawa, Canada.

Author: Matsyshen D, Svanas G, Maynard J, Tam M, Burgess Hay DC

Publication date: July 2003

Region: Global

This report provides an overview of Nicaragua's health system and diagnostic needs. It is supported by individual case studies on Chagas disease, dengue, and malaria in Nicaragua. These studies focus on several factors influencing the health care system in Nicaragua, including recent trends, regional and national control strategies, financing and partnerships, and the unmet clinical needs associated with each illness.

Author: Sequeira M, Espinoza H, Amador JJ, Domingo G, Quintanilla M, de los Santos T

Publication date: February 2011

Region: Latin America

Part of the Technology Updates series, this fact sheet describes PATH's work to develop technologies that facilitate electricity-free, instrument-free nucleic acid amplification.

Publication date: April 2012

Region: Global

Part of series: Technology Updates

A report on selecting and testing phase change materials for their ability to maintain a temperature range for duration sufficient to drive a PCR reaction.  Presented at: Microfluidics, BioMEMS, and Medical Microsystems VI, January 22, 2008; San Jose, CA.

Author: Tang D, LaBarre P, Weigl BH, Stayton PS

Publication date: January 2008

Region: Global

PATH has demonstrated the use of CaO for heat and a proprietary engineered phase change material (EPCM) to maintain an assay mixture within a narrow temperature range suitable for isothermal amplification. We are currently working to develop, integrate, and validate components of this NAAT kit. Presented at: AACC 42nd Annual Oak Ridge Conference, April 22, 2010; San Jose, CA.

Author: LaBarre P, Beddoe A, Gerlach J, et al

Publication date: April 2010

Region: Global

The PATH-Lemos Chagas rapid test has great potential as a highly sensitive diagnostic test for Chagas disease, suitable for use at the point-of-care.  Presented at: AACC 42nd Annual Oak Ridge Conference, April 22, 2010; San Jose, CA.

Author: Barfield CA, Barney RS, Crudder CH, et al

Publication date: April 2010

Region: Global

This brochure outlines PATH's work in China, with emphasis on public-private partnerships for product development. Areas of focus include vaccines and immunization, health technologies, and women's health.

Publication date: November 2012

Region: Asia

Since 2001, PATH has brought our global health expertise and innovative approaches to the fight against tuberculosis. We work hand in hand with global partners with a special focus on high-burden countries.

Publication date: February 2013

Region: Global

Launched in 2002, this PATH website explores rapid diagnostic tests for infectiuos diseases, and provides information useful to international public health officials.

Publication date: 2008

Region: Global

Part of series: Websites

The global diabetes epidemic impacts pregnant women and their babies. This poster describes a rapid, low-cost, non-fasting screening assay proposed by PATH to be used at antenatal care visits. The test would enable interventions to prevent or delay diabetes in the mother and child.

Publication date: July 2012

Region: Global

Part of the Technology Updates series, this fact sheet describes PATH's work to develop a rapid, easy-to-read, low-cost test for malaria.

Publication date: May 2009

Region: Global

Part of series: Technology Updates

Part of the Technology Updates series, this fact sheet describes PATH's work to develop rapid tests for cervical cancer.

Publication date: April 2012

Region: Global

Part of series: Technology Updates

This guide introduces the retinol binding protein enzyme immunoassay (RBP-EIA) to potential advocates and users, and provides information about its prospective role in public health.

Author: Hix J; Levin C; Gorstein J

Publication date: 2003

Region: Global

This document serves as a guide to phlebotomists and a training aid in the proper methods of obtaining blood samples for analysis by the retinol-binding protein enzyme immunoassay (RBP-EIA) used in testing for vitamin A deficiency.

Publication date: 2005

Region: Global

This document summarizes available evidence for the validation and establishment of a rapid, field-based tool for the assessment of vitamin A deficiency using the retinol-binding protein immunoassay (RBP-EIA) test.

Publication date: 2006

Region: Global

This Alliance for Cervical Cancer Prevention fact sheet summarizes evidence published since 2009 on cervical cancer screening approaches for low-resource settings.

Publication date: May 2011

Region: Global

The fourth annual policy report from the Global Health Technologies Coalition outlines actions the United States can take to help reduce deaths, extend lives, and secure healthier futures by supporting research for new health tools.

Publication date: February 2013

Region: North America and Europe

Part of series: GHTC's annual policy reports

Part of the Technology Updates series, this fact sheet describes PATH's work to develop a rapid, low-cost test to detect vitamin A deficiency.

Publication date: April 2012

Region: Global

Part of series: Technology Updates

Part of the Technology Updates series, this fact sheet describes PATH's work to develop a simple, affordable test for multidrug-resistant tuberculosis.

Publication date: April 2012

Region: Global

Part of series: Technology Updates